Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. - Wikidata - awgldk - TriplyDB

Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.

Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.

http://www.wikidata.org/entity/Q35845633

about

The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65 Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model Cytomegalovirus induces abnormal chondrogenesis and osteogenesis during embryonic mandibular development.NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: studies with ts13 cells The phosphorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate-early protein IE2/IEP86 affects temporal viral gene expression.Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.Transcription factor Sp1 mediates cell-specific trans-activation of the human cytomegalovirus DNA polymerase gene promoter by immediate-early protein IE86 in glioblastoma U373MG cells.Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function.Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2.Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38.Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-κB activation.Two Sp1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication.Biphasic regulation of A20 gene expression during human cytomegalovirus infection.Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3'-OH kinase pathway and the cellular kinase Akt.RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients.The human cytomegalovirus UL26 protein antagonizes NF-κB activation.Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo.Strain variations in single amino acids of the 86-kilodalton human cytomegalovirus major immediate-early protein (IE2) affect its functional and biochemical properties: implications of dynamic protein conformation.Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation Varicella-zoster virus inhibition of the NF-κB pathway during infection of human dendritic cells: role for open reading frame 61 as a modulator of NF-κB activity Analysis of splice variants of the immediate-early 1 region of human cytomegalovirus.Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic mice Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha.Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha.The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter.The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection

P2860

Q24300688-E9A9DAEB-82D8-4F4F-9BF6-BCB63411F03E Q24315863-36604EF0-84CB-4399-8688-A8DF4658F5E2 Q24802610-8284D67A-0202-4DC5-A322-6DC7B06E11F4 Q28193489-1684A74E-3963-426B-BBCC-6653BB3F282A Q28344246-6D09FCC9-03F1-4CA9-890E-7F16B46D4677 Q28534550-62228421-2BBF-4572-8E05-738BDA742E23 Q33256757-6E8CD638-E1E5-437B-AD8C-DB87AFD43735 Q33326039-15D3E671-8963-4DC6-9795-E611D53B0E41 Q33557568-3C6BCD5E-8D2E-4C10-A9D4-BD7B6D2DA4D5 Q33643399-8C85955F-4D71-40B7-ABDD-719D583377BB Q33716504-A410D641-55DE-4781-AE3F-0C590D2A4379 Q33781921-A110E4CF-1507-47FB-8710-2D400D09069A Q33781947-FE4B337B-CD2E-481C-996F-D9E6A24936A3 Q33782285-F7C9660C-0C79-4F84-9A94-CF5EC4348A67 Q33784945-61CBC952-6FB8-4837-8803-0D7A6152F537 Q33793056-18B7C23F-5192-4912-9BA5-40C22F0A35E7 Q33842473-7CBDD970-ED06-472E-8575-0D0D90C2DF2B Q33886711-CDB92316-11BD-4EDC-8D81-77732E59EA81 Q33900418-31CFE444-30BA-4EB4-A341-07ED6CD650B1 Q33908697-7042C61D-CA3B-42D6-AFA7-4B889532C2A2 Q33925240-ED18190F-844A-4F0A-9B11-0970048B23A4 Q33957986-D2E7E60F-AA8F-4FF2-89BF-7C8BEF6F4B08 Q34055763-D68C5B1D-3C5B-4463-BE2B-4D191F7126D3 Q34336521-412B8C3A-F2F5-4EA2-B369-238A4D6C6B8A Q34364116-37037083-F324-41F5-9407-6CF94BACCB57 Q34589568-53DF91AE-A8EF-4035-8C0C-FA352C2BFE24 Q34594875-7458AEEC-C85A-49CA-9204-E6A3E6D8E219 Q34648184-1ADA71C9-642D-42E2-82F4-F2FC5AF70A7A Q34856545-4B2531F3-02CD-4AFA-A933-48AFDB9D40BF Q34858442-4B302943-E7CC-4F30-82A8-29FC7D198C8A Q35140023-51B40741-65C6-4117-B394-CBD0B0E588DD Q35551066-C2BD1553-88B2-45CD-AD54-732959862CF0 Q35665805-B72E3580-1926-4415-9A2F-8007E87F15DA Q35703488-BE0DB6E0-8015-45D2-A04A-0A83D3EF8625 Q35786286-5FD83FF5-A5AE-4D50-A47B-629A289406C7 Q35789277-D5497BA7-6D7B-4C6B-A5B3-14D10A204796 Q35846755-3A4CE22C-C98D-4818-9565-2DAB8D925856 Q35857513-F527EFE4-D8E3-41FB-BEF9-01A825CC8E1F Q35872328-296D6E9C-C100-4250-B99D-320CA79882C1 Q35887796-7348EBA4-9807-49BA-809E-B0B88AFBE901

P2860

Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.

http://www.wikidata.org/entity/Q35845633

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Human cytomegalovirus upregula ...... B p105/p50 and p65 promoters.

@ast

Human cytomegalovirus upregula ...... B p105/p50 and p65 promoters.

@en

type

label

Human cytomegalovirus upregula ...... B p105/p50 and p65 promoters.

@ast

Human cytomegalovirus upregula ...... B p105/p50 and p65 promoters.

@en

prefLabel

Human cytomegalovirus upregula ...... B p105/p50 and p65 promoters.

@ast

Human cytomegalovirus upregula ...... B p105/p50 and p65 promoters.

@en

P1433

Q35845633-2B0C1252-FD15-4012-907C-EBBF29D191F0

P1476

Q35845633-2F36AA37-143B-4813-912F-B3DBC82214E8

P2093

Q35845633-01FAB93A-5898-40CB-BD84-2980C958D433

Q35845633-09FA4272-5A87-4884-998B-43EF7B0611FF

Q35845633-819F2C44-AEEF-4E71-83E7-F5C837BC4BE4

Q35845633-D2EBBA30-B9A3-4C68-8282-0B34961C3182

P2860

Q35845633-14B19EAC-E9E7-452F-B286-D389964135DA

Q35845633-1640AA83-E1C5-4EA2-B58F-216E7C8A4796

Q35845633-19ED0400-656B-4681-88C4-418E04CBA831

Q35845633-1A09DD8C-9BB0-40CD-A00C-1019DFCFE97A

Q35845633-1B97DDD5-3589-4E0D-A0D1-8FFD25763B43

Q35845633-1DAB37D2-C7DC-4C66-9A37-4D358F1CAEDE

Q35845633-2139382E-AACF-49C6-BD93-A2AA11BB1F48

Q35845633-2360668B-0267-4CC0-BFED-37808221AC78

Q35845633-25B2CDCE-AA1B-4A9E-B03D-F07F32524B1D

Q35845633-25E7A974-AE3A-4203-A2CA-E45458D133DA

P304

Q35845633-3513392B-A8E0-44AB-A744-4D4D5A6EA17D

P31

Q35845633-D776EE15-93F6-42EE-A477-29A306FC0BF9

P407

Q35845633-F3DB8AF9-52EB-4786-B377-AA6294BB7BC6

P433

Q35845633-13ED6678-72A9-439D-A60B-E93437B3E7A4

P478

Q35845633-55838D7B-333B-4873-9F7D-F28B415C959F

P577

Q35845633-A1384430-DCE1-4B9E-ADF7-F6D8CB3522B0

P698

Q35845633-11D1856D-FC27-44E5-A36C-3984439DBBCF

P921

Q35845633-1DB3D4D1-8CD2-43DD-ADCB-18A4E3E90964

P932

Q35845633-589C6693-DD73-4841-86CC-0E0A34B5D94E

P1433

Journal of Virology

P1476

Human cytomegalovirus upregula ...... B p105/p50 and p65 promoters.

@en

P2093

A D Yurochko

http://www.w3.org/2001/XMLSchema#string

E S Huang

http://www.w3.org/2001/XMLSchema#string

S M Huong

http://www.w3.org/2001/XMLSchema#string

T F Kowalik

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation

I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding

Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha

Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus

Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression

The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

Synergistic activation by the glutamine-rich domains of human transcription factor Sp1

P304

5391-5400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

1995-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7636984

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

189383

http://www.w3.org/2001/XMLSchema#string